# Connected Care for Type 2 Diabetes Self-Management

Study · id `cardio:ct-nct07149610` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07149610](<https://clinicaltrials.gov/study/NCT07149610>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07149610

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 388 participants.

## Technical summary

Registry record NCT07149610. Randomized; no masking; primary purpose treatment. Start 2025-10-13 (actual); primary completion 2026-11-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 388 participants (planned count; ClinicalTrials.gov record NCT07149610, source copy `cardio:ctgov-nct07149610-2026-08-18`, retrieved 2026-10-26)
- Started: 2025-10-13 (actual) (ClinicalTrials.gov record NCT07149610, source copy `cardio:ctgov-nct07149610-2026-08-18`, retrieved 2026-10-26)
- Primary completion: 2026-11-30 (anticipated) (ClinicalTrials.gov record NCT07149610, source copy `cardio:ctgov-nct07149610-2026-08-18`, retrieved 2026-10-26)
- Completion: 2026-12-31 (anticipated) (ClinicalTrials.gov record NCT07149610, source copy `cardio:ctgov-nct07149610-2026-08-18`, retrieved 2026-10-26)
- Countries: Italy (ClinicalTrials.gov record NCT07149610, source copy `cardio:ctgov-nct07149610-2026-08-18`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07149610-2026-08-18`, retrieved 2026-10-26)

## The registry's words

- Brief title: Connected Care for Type 2 Diabetes Self-Management
- Acronym: RCT\_SM
- Condition: Diabetes Type 2
- Intervention (Device): M-health solution classified as Class I Medical Devices, equipped with a CE certificate. The m-health solution will be integrated with the EPR currently used by the CADs of the Marche region
- Lead sponsor: Marche Region Regional Health Agency
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)

## Provenance

Content hash: c27435be22a59ff143296d6df89e7defa4134d36f968bf78192ec76fa551f8b2
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
